MAX
Calendrier Invesco Nasdaq Biotechnology ETF
Calendrier simple
Calendrier prolongé
Les principaux paramètres
| 10 rentabilité d'été | 0 |
| 3 rentabilité d'été | -1.82 |
| 5 rentabilité d'été | 0 |
| Bêta | -0.86 |
| Commission | 0.19 |
| Devise | usd |
| ISIN CODE | US46138G5999 |
| Indice | NASDAQ / Biotechnology |
| La date de la base | 2021-06-09 |
| Le nombre d'entreprises | 48 |
| P / BV moyen | 3.66 |
| P / E moyen | -33.73 |
| P / S moyen | 4.82 |
| Pays | USA |
| Pays ISO | US |
| Propriétaire | Invesco |
| Rentabilité annuelle | 37.34 |
| Rentabilité divine | 0.73 |
| Région | North America |
| Région | U.S. |
| Se concentrer | Health Care |
| Segment | Equity: U.S. Pharma, Biotech & Life Sciences |
| Site web | Système |
| Stratégie | Exchange-specific |
| Taille | Large-Cap |
| Top 10 des émetteurs,% | 46.43 |
| Type d'actif | Equity |
| Changement dans la journée | 0% 28.801 $ |
| Changement de la semaine | -3.01% 29.696 $ |
| Changement en un mois | -2.13% 29.429 $ |
| Changement en 3 mois | +1.49% 28.377 $ |
| Changement en six mois | +7.83% 26.71 $ |
| Changement pour l'année | +37.34% 20.97 $ |
| Changement depuis le début de l'année | -0.0312% 28.81 $ |
Payer l'abonnement
Plus de fonctionnalités et de données pour l'analyse des entreprises et du portefeuille sont disponibles par abonnement
Meilleures entreprises
| Nom | Industrie | Partager, % | P/BV | P/S | P/E | EV/Ebitda | Rendement des dividendes | |
| #1 |
 Vertex |
Healthcare | 8.7193 | 6.28 | 9.35 | -186.72 | 205.99 | 0 |
| #2 |
 Gilead Sciences |
Healthcare | 7.7858 | 6 | 4.02 | 240.57 | 29.81 | 2.59 |
| #3 |
 Amgen |
Healthcare | 7.7143 | 23.87 | 4.2 | 34.3 | 14.11 | 3.17 |
| #4 |
 Regeneron |
Healthcare | 5.9529 | 2.75 | 5.69 | 18.33 | 15.25 | 0.22 |
| #5 |
 AstraZeneca PLC |
Healthcare | 4.1131 | 10.03 | 7.58 | 58.27 | 28.15 | 3.79 |
| #6 |
 Alnylam Pharmaceuticals, Inc. |
Healthcare | 3.9854 | 233.68 | 13.4 | -197.3 | -170.29 | 0 |
| #7 |
 Insmed Incorporated |
Healthcare | 2.7697 | 39.59 | 31.06 | -21.8 | -13.25 | 0 |
| #8 |
 Biogen |
Healthcare | 1.9882 | 1.31 | 2.26 | 13.43 | 9.25 | 0 |
| #9 |
 argenx SE |
Healthcare | 1.734 | 7.35 | 18.45 | 48.51 | 370.32 | 0 |
| #10 |
 Illumina |
Healthcare | 1.6675 | 8.95 | 4.86 | -12.66 | -31.36 | 0 |
Similaire ETF
Autres ETF de la société de gestion
| Nom | Classe | Catégorie | Commission | Rentabilité annuelle |
| Equity | 0.2 | 13.84 | ||
| Equity | 0.2 | 11.54 | ||
| Equity | 0.02 | 14.11 | ||
| Equity | 0.15 | 13.9 | ||
| Equity | 0.15 | 12.5 | ||
| Equity | 0.15 | 11.76 | ||
| Bond | 0.65 | -2.63 | ||
| Equity | 0.39 | 17.14 | ||
| Equity | 0.29 | 9.98 | ||
| Commodity | 0.59 | 17.84 | ||
| Equity | 0.2 | 13.36 | ||
| Bond | 0.1 | -0.27 | ||
| Equity | 0.4 | 17.34 | ||
| Bond | 0.1 | -0.14 | ||
| Equity | 0.58 | 33.36 | ||
| Bond | 0.1 | -0.0256 | ||
| Equity | 0.39 | 15.49 | ||
| Equity | 0.3 | 9.65 | ||
| Bond | 0.28 | 4.2 | ||
| Equity | 0.34 | 15.67 | ||
| Equity | 0.39 | 18.35 | ||
| Equity | 0.6 | 1.67 | ||
| Equity | 0.35 | 17.61 | ||
| Bond | 0.23 | -0.0199 | ||
| Bond | 0.1 | 0.33 | ||
| Commodity | 0.85 | 18.27 | ||
| Equity | 0.45 | 24.64 | ||
| Bond | 0.08 | -0.17 | ||
| Multi-Asset | 0.5 | -0.37 | ||
| Bond | 0.1 | 0.56 |
Description Invesco Nasdaq Biotechnology ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
Basé sur des sources: porti.ru
